ACP-002

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameACP-002
Drug Alias NameTransCon Hydrogel Insulininsulin (Ascendis Pharma/Sanofi)insulin (Complex Biosystems)ACP-002
ClassificationBiologics
Mechanisms of ActionInsulin ligandInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAscendis Pharma A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiAscendis Pharma A/S
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A